There’s nothing to make you feel old like finding out that something you used to do all the time is now completely beyond you I decided to do some press-ups. They’re good for you, apparently. A calisthenic classic. This much I picked up in a doomscrolling session. Some algorithm somewhere must have decided I’d be open to the idea and, not for the first time, the algorithm was right. I used to do l...
There’s nothing to make you feel old like finding out that something you used to do all the time is now completely beyond you I decided to do some press-ups. They’re good for you, apparently. A calisthenic classic. This much I picked up in a doomscrolling session. Some algorithm somewhere must have decided I’d be open to the idea and, not for the first time, the algorithm was right. I used to do lots of press-ups, perhaps 20 or 30, most days. I can recall how this started. It was 1985 and I was spending a gap year working for my dad’s scaffolding company. That I was the boss’s son didn’t stop my workmates from sharing with me their thoughts on my shortcomings. One such shortcoming was identified by a muscly scaffolder called Andy. “Your arms are puny,” he told me. “Do some press-ups,” Andy advised. So that’s what I did, and my arms bulked up a bit. Thank you, Andy. Continue reading...
Micron Technology (NASDAQ:MU) shares are up 6% in midday trading, leading a broad-based rally across AI chip names. Advanced Micro Devices (NASDAQ:AMD) stock gained 4% and Broadcom (NASDAQ:AVGO) shares are also up 4% as investors re-embrace the AI infrastructure trade on Wednesday. The catalyst is a renewed wave of conviction around AI chip demand, with ... Micron Soars 6%, AMD Rallies 4%, Broadco...
Micron Technology (NASDAQ:MU) shares are up 6% in midday trading, leading a broad-based rally across AI chip names. Advanced Micro Devices (NASDAQ:AMD) stock gained 4% and Broadcom (NASDAQ:AVGO) shares are also up 4% as investors re-embrace the AI infrastructure trade on Wednesday. The catalyst is a renewed wave of conviction around AI chip demand, with ... Micron Soars 6%, AMD Rallies 4%, Broadcom Climbs 4% on Reignited AI Chip Demand
In recent weeks, Oracle has rolled out a broad suite of agentic AI applications across its Fusion Cloud portfolio, expanded multicloud connectivity with AWS and Google Cloud, and advanced Oracle Health’s digital check-in capabilities under the CMS “Kill the Clipboard” initiative. Together, these moves highlight Oracle’s push to embed AI-driven automation deeply into mission-critical workflows whil...
In recent weeks, Oracle has rolled out a broad suite of agentic AI applications across its Fusion Cloud portfolio, expanded multicloud connectivity with AWS and Google Cloud, and advanced Oracle Health’s digital check-in capabilities under the CMS “Kill the Clipboard” initiative. Together, these moves highlight Oracle’s push to embed AI-driven automation deeply into mission-critical workflows while positioning its cloud infrastructure as a neutral, interoperable backbone across hyperscalers...
The Mexican government said it was unaware that two US officials took part in an operation to dismantle a drug lab in northern Mexico, a development that threatens to escalate tensions with Washington over security and sovereignty. The US officials died shortly after the operation. At a press briefing, President Claudia Sheinbaum said Mexican security officials involved in the effort were never to...
The Mexican government said it was unaware that two US officials took part in an operation to dismantle a drug lab in northern Mexico, a development that threatens to escalate tensions with Washington over security and sovereignty. The US officials died shortly after the operation. At a press briefing, President Claudia Sheinbaum said Mexican security officials involved in the effort were never told about the presence of foreigners, which she described as a clear breach of security protocols. A person familiar with the matter confirmed that the two US nationals worked for the CIA. “The Defense Ministry was unaware that there were individuals involved who were not Mexican citizens and who were not affiliated with state security agencies,” Sheinbaum said on Wednesday. “This is something that should not be taken lightly.” The president emphasized that communications with the US government, especially on matters related to security, must go through Mexico’s federal government.
Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Wednesday's key moments. 1. Stocks advanced Wednesday on news that President Donald Trump extended the ceasefire agreement between the U.S. and Iran. A batch of solid earnings, including from Club names Boeing and GE Vernova , also helped lift the market. Jim Cramer said ...
Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Wednesday's key moments. 1. Stocks advanced Wednesday on news that President Donald Trump extended the ceasefire agreement between the U.S. and Iran. A batch of solid earnings, including from Club names Boeing and GE Vernova , also helped lift the market. Jim Cramer said that when war worries abate, stocks can trade on earnings. "What you can do is look to stocks that do really well and actually expect them to go up," he said. However, the S & P Short Range Oscillator still points to a very overbought market, despite coming down a bit after back-to-back losses for the S & P 500 and the Nasdaq . 2. GE Vernova surged over 12% after a blowout quarter. After a move like that, Jim said, "You have to hold this [stock] because this may be one for the ages." The company topped expectations, with revenue up 16% year over year to $9.3 billion. GE Vernova saw strong equipment orders, leading management to expect to reach a $200 billion backlog in 2027, a year sooner than anticipated. Power equipment pricing for the first half of 2026 is also expected to go up. Jim added that GE Vernova is the best company out there, with its natural gas turbines and other products, to power data centers. 3. Honeywell and Dover report earnings Thursday morning. Jim warned that Honeywell shares often perform poorly after earnings. Be patient. He said it's impossible to get out and get back into the stock, noting Honeywell is moving closer to the breakup catalyst we've been waiting for. As for Dover, the company expects a year of accelerating growth, according to recent commentary from CEO Richard Tobin. We'll see if that starts to show up in the numbers. However, Jim is not too hot on the stock. "I'm putting Dover on that short leash," he added. 4. Stocks covered in Wednesday's rapid fire at the end of the video were: Vertiv , AT & T , United Airlines , Best Buy , and A...
Rivian’s new R2 model has begun rolling off the manufacturing floor in Normal, Illinois, despite damage to the factory from a tornado over the weekend. The smaller, more affordable SUV is seen as crucial to driving profitability for the electric vehicle maker. Rivian CEO RJ Scaringe joins Caroline Hyde and Ed Ludlow on "Bloomberg Tech." (Source: Bloomberg)
Rivian’s new R2 model has begun rolling off the manufacturing floor in Normal, Illinois, despite damage to the factory from a tornado over the weekend. The smaller, more affordable SUV is seen as crucial to driving profitability for the electric vehicle maker. Rivian CEO RJ Scaringe joins Caroline Hyde and Ed Ludlow on "Bloomberg Tech." (Source: Bloomberg)
Elon Musk waves to the crowd during the 56th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January 22, 2026. Denis Balibouse | Reuters Tesla reports first-quarter results after the bell on Wednesday. Here's what Wall Street is expecting, according estimates compiled by LSEG: Earnings per share : 37 cents estimated Revenue : $22.64 billion estimated Tesla has underperformed all o...
Elon Musk waves to the crowd during the 56th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January 22, 2026. Denis Balibouse | Reuters Tesla reports first-quarter results after the bell on Wednesday. Here's what Wall Street is expecting, according estimates compiled by LSEG: Earnings per share : 37 cents estimated Revenue : $22.64 billion estimated Tesla has underperformed all of its megacap peers on Wall Street so far this year, with the stock down 14% as of Tuesday's close, weighed down by lackluster sales in the company's core automotive business. The S&P 500 is up more than 3%. Analysts expect revenue growth of about 17% from $19.3 billion a year earlier. That would mark the company's most robust period for growth since mid-2023. The past year has been a struggle due to competitors like China's Xiaomi and BYD, which offer high-tech but lower cost models against Tesla's aging lineup of EVs. Tesla also faces an ongoing consumer backlash in response to CEO Elon Musk's work with the Trump administration, his incendiary political rhetoric and endorsements of far-right political figures. Earlier this month, Tesla reported 358,023 vehicle deliveries for the first quarter, which was lower than the prior quarter and up about 6% from a year earlier. Tesla has recorded annual declines in the past two years. Musk has been trying to change the narrative by focusing on the company's efforts in self-driving technology and humanoid robots. While the company is testing a small number of driverless cars in its ride-hailing service in Texas, Tesla still relies on EV sales for the bulk of its revenue, and doesn't yet sell a robotaxi-ready vehicle. Tesla does sell an FSD (Supervised) system for $99 per month but it requires active supervision by a human who remains attentive to the road and ready to steer or brake at any time. The company recently scored permission to sell a version of FSD (Supervised) in the Netherlands, and is seeking broader approval in Europe....
Earnings Call Insights: Masco Corporation (MAS) Q1 2026 Management view "Jai Shah, Group President, Plumbing and Wellness; and Rick Marshall, Vice President of Masco Operating System, recently announced their intent to retire from Masco later this summer" (President, CEO & Director Jonathon Nudi). "With Jai's retirement... the leaders of our 4 largest businesses: Delta, Hansgrohe, BEHR and Watkins...
Earnings Call Insights: Masco Corporation (MAS) Q1 2026 Management view "Jai Shah, Group President, Plumbing and Wellness; and Rick Marshall, Vice President of Masco Operating System, recently announced their intent to retire from Masco later this summer" (President, CEO & Director Jonathon Nudi). "With Jai's retirement... the leaders of our 4 largest businesses: Delta, Hansgrohe, BEHR and Watkins Wellness will now all report directly to me... we are adding 2 new leaders to our executive committee with expertise in supply chain and procurement." "Our integration of Liberty Hardware into Delta Faucet Company is on track" and "Restructuring actions to streamline our business, reduce headcount and optimize operations are ongoing" (President, CEO & Director Jonathon Nudi). "We incurred approximately $8 million in restructuring charges in the first quarter, and we continue to expect approximately $50 million in total charges in 2026." "Net sales increased 6%" and "Earnings per share grew 20% during the quarter to $1.04 per share" (President, CEO & Director Jonathon Nudi). "Plumbing product sales increased 7% in local currency" with "International plumbing sales increased 1% in local currency... partially offset by the ongoing weak market in China." "Our strong cash flow allowed us to return $267 million to shareholders this quarter" (President, CEO & Director Jonathon Nudi). "We believe it is prudent to maintain our 2026 earnings per share guidance in the range of $4.10 to $4.30 per share" and "our sales will now be up low single digits for 2026" (President, CEO & Director Nudi). "Operating profit grew 13% to $324 million" and "Gross margin expanded 10 basis points to 36%" (VP, CFO & Treasurer Richard Westenberg). "Operating profit was driven by pricing actions and cost savings initiatives partially offset by higher tariff and commodity costs." Outlook "We expect 2026 sales to be up low single digits versus our previous guide of flat to up low single digits" and "we cont...
Michael Vi/iStock Editorial via Getty Images Roche ( RHHBF ) ( RHHBY ) has announced plans to seek regulatory review for an experimental therapy for multiple sclerosis, an autoimmune condition affecting the central nervous system, even as its late-stage trial data indicated several patient deaths. On Tuesday, the Swiss drugmaker shared new data from its Phase 3 FENhance 1 and 2 studies, which test...
Michael Vi/iStock Editorial via Getty Images Roche ( RHHBF ) ( RHHBY ) has announced plans to seek regulatory review for an experimental therapy for multiple sclerosis, an autoimmune condition affecting the central nervous system, even as its late-stage trial data indicated several patient deaths. On Tuesday, the Swiss drugmaker shared new data from its Phase 3 FENhance 1 and 2 studies, which tested its MS therapy fenebrutinib against teriflunomide, a rival drug marketed by Sanofi ( SNY ) as Aubagio. The oral Bruton’s tyrosine kinase (BTK) inhibitor had already met the primary endpoints related to annualized relapse rates in FENhance 1 and 2, as well as one related to non-inferiority against Roche’s ( RHHBY ) own MS therapy Ocrevus in its FENtrepid Phase 3 trial. However, citing seven deaths in the fenebrutinib arm across both FENhance 1 and 2 trials, the company attributed the fatalities to factors including infections and complications linked to type 1 diabetes. “The collective positive results across all three pivotal studies demonstrate that fenebrutinib consistently showed a profound benefit on relapsing and progressive disease biology,” Roche ( RHHBY ) said, adding that it will submit data from all three trials to regulators. In February, citing epidemiological studies, the company said that fatality rates are higher in MS patients compared to the general population after results from FENtrepid indicated a 1.4% mortality rate in the fenebrutinib arm. More on Roche Holding Roche Vs. Eli Lilly: Nvidia Deals, Obesity Battles Stoke Rivalry (I'd Buy Both) Roche Holding AG (RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline - Slideshow Roche Falters In A Key Breast Cancer Readout FDA accepts Roche application for Gazyva/Gazyvaro in common lupus treatment Sarepta/ Roche Duchenne therapy to face new late-stage trial targeting EU nod
Lawyers for oligarch claim freezing of £5.3bn of assets ‘unfair and abusive’ amid row over use of funds for Ukraine Roman Abramovich has gone to the European court of human rights (ECHR), claiming that a criminal investigation into his financial affairs by the Jersey authorities has breached his human rights, according to reports. The former owner of Chelsea FC, who is under UK sanctions over his ...
Lawyers for oligarch claim freezing of £5.3bn of assets ‘unfair and abusive’ amid row over use of funds for Ukraine Roman Abramovich has gone to the European court of human rights (ECHR), claiming that a criminal investigation into his financial affairs by the Jersey authorities has breached his human rights, according to reports. The former owner of Chelsea FC, who is under UK sanctions over his links to Vladimir Putin, is being investigated in Jersey over allegations of corruption and money laundering. Continue reading...